Four novel furoxan derivatives were synthesized, characterized and evaluated for in vitro activity against promastigote form of Leishmania amazonensis and Leishmania infantum, and amastigote form of L. infantum. Compound 7 presented low cytotoxicity, being 30 times less toxic than pentamidine. All compounds were more active against L. infantum than L. amazonensis promastigote form, with IC50 reaching values around 8 µM.
INTRODUCTION:
Leishmaniasis is a neglected tropical disease caused by more than 20 species of the protozoan parasite Leishmania [1] and transmitted to humans by the bite of the female sanfly of the genera Phlebotomus, which is the only vector responsible for transmitting the disease [2] .
There are three forms of leishmaniasis: cutaneous, visceral and mucocutaneous.
Afghanistan, Algeria, Brazil and Colombia are among the countries with the majority of cutaneous leishmaniasis cases. Only in 2015, Brazil has reported more than one thousand new cases of visceral leishmanisis [3] .
The increasing drug resistance in leishmaniasis treatment and the lack of recent costeffective drugs are important issues to be considered in order to discover new drugs.
Therefore, there is a high urgency for new compounds active against leishmaniasis. In the present study, four furoxan derivatives were evaluated against promastigote and amastigote forms of L. amazonensis and L. infantum, which are responsible for cutaneous and visceral leishmaniasis, respectively.
METHODS

Chemistry
1 H nuclear magnetic resonance (NMR) spectra were scanned on a Bruker Fourier 300 (300-MHz) NMR spectrometer using dimethyl sulfoxide (DMSO)-d6 as the solvent.
Chemical shifts were expressed in parts per million (ppm) relative to tetramethylsilane.
The compounds 1, 2a, 2b, 5, 6, 10 and 13 were synthesized according to a previously described methodology [4] [5] [6] [7] [8] [9] . of aminoguanidine hydrochloride (45mg; 0,4mmol) and 3mL of ethanol was stirred at room temperature for 2 to 3h and monitored by TLC (100% ethyl acetate). Then, the precipitated was filtered and washed with cold distilled water, dried at room temperature to give compounds 3a and 3b as a white powder.
Preparation of compound 7.
A mixture of 4-phenyl-1,2,5-oxadiazol-3-carbaldehyde 2-oxide (100mg, 0.5mmol) (compound 6), a solution of aminoguanidine hydrochloride (65mg; 0.6mmol) and 3mL of ethanol was stirred at room temperature for 2 to 3h and monitored by TLC (100% ethyl acetate). Then, the precipitated was filtered and washed with cold distilled water, dried at room temperature to give compound 7 as yellow powder.
Preparation of compound 11. A mixture of 6-formyl-2,1,3-benzoxadiazol 1-oxide (100mg, 0.6mmol) (compound 10), a solution of aminoguanidine hydrochloride (78mg; 0.7mmol) and 3mL of ethanol was stirred at room temperature for 2 to 3h and monitored by TLC (100% ethyl acetate). Then, the precipitated was filtered and washed with cold distilled water, dried at room temperature to give compound 11 as yellow powder.
Leishmanicidal activity
Animals
Adult male Swiss albino mice (20-35 g) were used in the experiments. They were housed in single-sex cages under a 12 h light:12 h dark cycle (lights on at 06:00) in a controlled-temperature room (22  2 °C). The mice had free access to food and water. method [10, 11] . Absorbances were read at 490 nm. The drug concentration corresponding to 50% of parasite growth inhibition was expressed as the inhibitory concentration (IC50) in μM [10] .
Cytotoxicity using murine macrophages
To access the cytotoxicity thioglycolate-stimulated mice were used to collect peritoneal macrophages. Murine peritoneal macrophages were seeded in 96 well flat-bottom plates . Cells without drugs were used as negative control. After that, plates were incubated for 24 h at 37 °C in a 5% CO2-air mixture.
Subsequently, the MTT colorimetric assay was carried out as described above. Absorbance was read in a 96-well plate reader (Robonik ® ) at 590 nm. The drug concentration corresponding to 50% of cell growth inhibition was expressed as the inhibitory concentration (CC50) [11] .
Amastigotes
Murine peritoneal macrophages were plated at 3x10 5 cells/well on coverslips (13 mm diameter) previously arranged in a 24-well plate in RPMI-1640 medium supplemented with 10% inactivated FBS, and allowed to adhere for 4 h at 37 °C in 5% CO2. Adherent macrophages were infected with promastigotes in the end of the exponential growth phase using a ratio of 5:1 for L. amazonensis per cell at 37 °C in 5% CO2 for 4 h. After that time, the non-internalized parasites were removed by washing, and infected cultures were incubated in RPMI-1640 medium for 24 h at 37 °C in 5% CO2 to parasite multiplication. However, for L. infantum macrophages were infected with promastigotes in the end of the exponential growth phase using was used at a ratio of 10:1 per cell at 37 °C in 5% CO2
for 18 h. After that time, infected cells were treated with different concentrations of the compounds and pentamidine (Sigma-Aldrich ® ) for 24 h.
The cells were then fixed in a methanol solution and stained with Giemsa. The number of amastigotes/100 cells and percent infected cells were determined. The concentration that caused a 50% decrease of growth inhibition compared to the control was determined by regression analysis and expressed as the inhibitory concentration (IC50) in μM [11] .
In silico prediction of ADME properties
In order to evaluate the human absorption of the compounds, the drugability through 'Lipinsk rule', Log P, water solubility and human absorption were predicted using the website pKCSM [12] .
RESULTS AND DISCUSSION
Chemistry:
The synthetic routes for the preparation of compounds 3a, 3b, 7, 11 are summarized in In silico prediction of ADME properties
Lipinski rule, LogP, water solubility and intestinal absorption were parameters predicted of the compounds and presented in Table 2 . For the Lipinski rule evaluation, the molecular weight, hydrogen bond donors and acceptors and LogP were analyzed, and the compounds were classified in "yes", as the compounds which follow the rules, and "no" as the compounds that do not follow the rules. Based on these parameters, all compounds exhibited drugability through Lipinski rules.
Intestinal absorption is a parameter that results from LogP and water solubility. The results presented here demonstrates that the predicted absorption of the compounds is close, varying from 67 to 70%. The compounds with higher absorption presented a higher water solubility, as observed in compounds 7 and 11. 
CONCLUSION
The new series of furoxan derivatives (compounds 3a, 3b, 7 and 11) were synthesized and characterized using analytical methods. The compounds presented CC50 values superior to that of pentamidine. The CC50 of compound 7 is 30 times higher than the control drug. All compounds have demonstrated to be more active against L. infantum than L. amazonensis, which leaded to an evaluation against amastigote form of L. infantum and resulted in IC50 three times higher than pentamidine. The in silico study has demonstrated that the compounds exhibits drug-like properties.
The results presented here demonstrate that the compounds showed low toxicity and interesting activity against L. infantum, therefore they are interesting prototypes against the visceral form of leishmaniasis.
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